Tag: Mayne Pharma
Mayne Pharma sells US retail generics portfolio for $134 million
Australian pharmaceutical manufacturing company Mayne Pharma has completed the sale of its US retail generics portfolio to Dr. Reddy’s Laboratories for approximately $134 million.
Mayne Pharma opens new manufacturing facility in the US
Australian-listed pharmaceutical company Mayne Pharma has officially opened its new oral solid-dose commercial manufacturing facility in Greenville, North Carolina, USA.
According to the company media statement, the $80...
Mayne Pharma to acquire a portfolio of US generic products from Teva and Allergen
ASX-listed specialty pharmaceutical company Mayne Pharma has entered into a binding agreement to acquire a portfolio of US generic products from Teva and Allergen for...
Featured Article
Balancing profit and sustainability in supply chains
Priorities in the supply chain are expanding, moving away from cost as the main driver behind purchasing decisions. Now, sustainability and ethical sourcing are grabbing a portion of the spotlight.
